Dana-Farber/Partners CancerCare
Since 1996, Dana-Farber/Partners CancerCare, the adult oncology collaboration of Dana-Farber Cancer Institute, Brigham and Women’s Hospital and the Massachusetts General Hospital Cancer Center, has enabled some of the world’s leading specialists to coordinate research, training, and quality of care improvements. These Harvard Medical School-affiliated hospitals are members of Dana-Farber/Harvard Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center and the largest cancer research collaboration in the nation.
Patient care is provided at Dana-Farber/Brigham and Women’s Cancer Center and the Massachusetts General Hospital Cancer Center. At each site patients are offered the highest standard of care and innovative treatments.
This partnership has fostered a greater exchange of ideas, improved efficiency, and speed in bringing discoveries from the laboratory bench to the patient's bedside, and created a robust training program for future physician scientists. With more than 700 clinical studies currently underway, patients have greater access to promising new therapies. As a result, investigators are better able to gain and share valuable insights that may lead to advances in cancer treatment for all. Through a comprehensive clinical training program, fellows work alongside leading cancer specialists, preparing them to become the future leaders in clinical and laboratory investigation and clinical teaching.
To learn more, visit the Dana-Farber/Partners Cancer Care site.
Physician Search
Easily search the Partners HealthCare network by specialty, hospital affiliation, or location.
Quality and Safety Report Card
Partners HealthCare is committed to making patient care better each day, across all parts of our system.
